Your session is about to expire
← Back to Search
Liothyronine (LT3) for Heart Failure (DOT3HF-HFpEF Trial)
DOT3HF-HFpEF Trial Summary
This trial is investigating whether thyroid hormone therapy with Liothyronine is safe and effective in people with heart failure and low triiodothyronine levels.
- Diastolic Heart Failure
- Hypothyroidism
DOT3HF-HFpEF Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.DOT3HF-HFpEF Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a history of liver disease called cirrhosis.You are taking medications that can affect how your body absorbs or processes thyroid hormone.You regularly take a certain type of medication called loop diuretics to help manage your symptoms.Based on a score, there is a high chance that you have a condition called HFpEF (heart failure with preserved ejection fraction) and there doesn't seem to be any other obvious reason for your symptoms, as determined by the doctor.You had a heart attack, heart procedure, or heart surgery within the past 2 months.You have stomach or intestinal conditions that make it hard for your body to absorb thyroid hormone.You are unable to do a test that measures your maximum oxygen consumption during exercise.You were hospitalized for heart failure in the last month.You have a heart condition called hypertrophic or restrictive cardiomyopathy, or a severe problem with one of your heart valves that has not been fixed.
- Group 1: Liothyronine (LT3)
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any patients currently being accepted into this trial?
"Yes, this is an active recruitment according to the information on clinicaltrials.gov. The study was posted on March 8th, 2020 and was last updated August 18th, 2020. They are looking for 28 patients from 1 site."
What are the main goals of this clinical trial?
"The purpose of this study is to observe the changes over a two-week period in order to assess the efficacy of the medication. Additionally, we will also be measuring NT-proBNP Levels, Quality of Life, and Actigraphy data to get a more well-rounded understanding of the effects of the intervention."
How many volunteers are participating in this clinical trial?
"That is accurate. According to the information available on clinicaltrials.gov, this study is still looking for participants. The posting went up on March 8th 2020 and was last edited on August 18th 2022. So far, only 28 people have signed up across 1 location."
Share this study with friends
Copy Link
Messenger